The Efficacy of Teriflunomide in Patients Who Received Prior Disease-Modifying Treatments: Subgroup Analyses of the Teriflunomide Phase 3 TEMSO and TOWER Studies

Multiple Sclerosis - United States
doi 10.1177/1352458517695468
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Clinical Efficacy of Teriflunomide Over a Fixed 2-Year Duration in the TOWER Study

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2018English

Clinical Recommendations on the Use of Teriflunomide

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Teriflunomide Treatment Reduces B Cells in Patients With MS

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2017English

Tolerability and Discontinuation Rates in Teriflunomide-Treated Patients. A Real-World Clinical Experience

Neurosciences
PsychiatryMental HealthNeurology
2018English

Teriflunomide in the Treatment of Multiple Sclerosis: Current Evidence and Future Prospects

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2014English

Efficacy and Safety of Sirukumab in Japanese Patients With Moderate to Severe Rheumatoid Arthritis Inadequately Controlled by Disease Modifying Anti-Rheumatic Drugs: Subgroup Analysis of a Phase 3 Study

Modern Rheumatology
MedicineRheumatology
2018English

Comparing Outcomes From Clinical Studies of Oral Disease-Modifying Therapies (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Relapsing MS: Assessing Absolute Differences Using a Number Needed to Treat Analysis

Multiple Sclerosis and Related Disorders
MedicineNeurology
2016English

Efficacy and Safety of Trabectedin or Dacarbazine for the Treatment of Patients With Uterine Leiomyosarcoma After Prior Chemotherapy: A Subgroup Analysis of the Randomized Phase 3 SAR-3007 Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy